Publications and References

Critical role of caveolin-1 in ocular neovascularization and multitargeted antiangiogenic effects of cavtratin via JNK

Yida Jianga, Xianchai Lina, Zhongshu Tanga, Chunsik Leea, Geng Tianb, Yuxiang Dua, Xiangke Yina, Xiangrong Rena, Lijuan Huanga, Zhimin Yea, Wei Chena, Fan Zhangc, Jia Mib, Zhiqin Gaod, Shasha Wanga, Qishan Chena, Liying Xinga, Bin Wange, Yihai Caof, William C. Sessa, Rong Jua, Yizhi Liua and Xuri Lia, PNAS Early Edition, PNAS.1706394114
 

Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice

Jean-Philippe Gratton,1,2,5,6 Michelle I. Lin,1,2,5 Jun Yu,1,2 Erik D. Weiss,1,2 Zao Li Jiang,1 Todd A. Fairchild,1,2 Yasuko Iwakiri,4 Roberto Groszmann,4 Kevin P. Claffey,3 Yung-Chi Cheng,1 and William C. Sessa1,2,*

CANCER CELL, July 2003, Vol. 4, 31-39

Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides

Pascal N. Bernatchez, Philip M. Bauer, Jun Yu, Jay S. Prendergast, Pingnian He, and William C. Sessa

PNAS, Vol. 102, No. 3, 761–766, January 18, 2005

In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation

Mariarosaria Bucci, Jean-Philippe Gratton, Radu Daniel Rudic, Lisette Acevedo, Fiorentina Roviezzo, Giuseppe Cirino & William C. Sessa

Nature Medicine, Volume 6, Number 12, 1362-1367, December 2000

© 2018 by CavtheRx, Inc.